Company Filing History:
Years Active: 2010
Title: Akella Satya Surya Visweswara Srinvas: Innovator in Heterocyclic Compounds
Introduction
Akella Satya Surya Visweswara Srinvas is a notable inventor based in Chennai, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds for therapeutic applications. His work focuses on innovative solutions for treating various diseases, including cancer and inflammatory conditions.
Latest Patents
Srinvas holds a patent for "Heterocyclic compounds as pSTAT3/IL-6 inhibitors." This invention relates to novel heterocyclic compounds of the general formula (I), which serve as IL-6 inhibitors. The patent encompasses their derivatives, analogs, tautomeric forms, stereoisomers, polymorphs, hydrates, solvates, pharmaceutically acceptable salts, compositions, metabolites, and prodrugs. The invention also provides a method for treating cancer, cancer cachexia, and inflammatory diseases mediated by cytokines such as IL-6 through pSTAT3 inhibition.
Career Highlights
Srinvas is associated with Orchid Research Laboratories Limited, where he continues to advance his research in the pharmaceutical field. His work has been instrumental in developing new therapeutic agents that target critical pathways in disease processes.
Collaborations
He collaborates with esteemed colleagues, including Siripragada Mahender Rao and Shikha Rani, to further enhance the impact of his research and innovations.
Conclusion
Akella Satya Surya Visweswara Srinvas exemplifies the spirit of innovation in the pharmaceutical industry. His contributions to the development of heterocyclic compounds highlight the potential for new treatments in combating serious health conditions.